EpiCept Pulls IPO Citing Conditions, Strategy

Pain management drugmaker EpiCept Corp. withdrew on Thursday a planned initial public offering of 5.5 million shares of common stock, citing market conditions and strategic reasons. The Englewood Cliffs, New Jersey-based company recently lowered the price range to between $6 per share and $7 per share from $11 to $13 each, and sought a Nasdaq listing under the symbol "EPCT".

()a href="http://www.reuters.com/newsArticle.jhtml?type=topNews&storyID=8548738" target="_blank">Reuters